Comment from Jitendra Pund

Dear sir/Madam, Please find here with my comments on line number 225 to 235 To ensure drug products meet regulatory standards, specifications and testing procedures must be scientifically justified, validated, and documented. This involves establishing clear analytical methods for detecting degradation products and proving their suitability under real-world conditions. Here’s a structured breakdown of how applicants and manufacturers typically approach this requirement: 1. Define Product Specifications *Establish scientifically sound standards for identity, strength, quality, purity, and stability. *Include limits for degradation products *Align with pharmacopeias or regulatory guidelines *Ensure specifications reflect patient safety and efficacy 2. Select Analytical Procedures * Choose appropriate methods to detect and quantify degradation products. *Use validated techniques (e.g., HPLC, GC, LC-MS) *Ensure sensitivity and specificity *Consider stability-indicating methods 3 Validate Analytical Methods *Demonstrate that chosen methods are reliable under actual use conditions. *Assess accuracy, precision, linearity, and robustness *Perform stress testing for degradation pathways *Document validation protocols and results 4. Develop Sampling Plans. *Create statistically justified sampling strategies to ensure representative testing. *Define batch size and sample number *Follow ICH Q6A/Q6B guidelines *Ensure reproducibility across lots 5.Document Testing Procedures * Maintain detailed records of analytical methods and validation of evidence. *Include SOPs and method descriptions *Provide raw data and validation reports *Ensure traceability and audit readiness This structure ensures that drug products consistently conform to regulatory expectations. By documenting validated analytical procedures and demonstrating their robustness, manufacturers build trust with regulators and safeguard patient health. Regards Jitendra Pund